Hongliang Zhang

Molecular Biology · with Leo · 2010

A researcher in the Science corpus: 1 paper; trusts 3 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Subfields

Whom Hongliang Zhang trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Yves Pommier
  2. S. Lapenna

Who trusts Hongliang Zhang overall

  1. Yves Pommier

Papers from Hongliang Zhang's perspective

Ordered by how strongly the researchers Hongliang Zhang trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Topoisomerase I inhibitors: camptothecins and beyond (Nature Reviews. Cancer)
  2. Cell cycle kinases as therapeutic targets for cancer (Nature reviews. Drug discovery)
  3. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma (Nature)
  4. The Bloom's syndrome helicase suppresses crossing over during homologous recombination (Nature)
  5. The role of PML in tumor suppression. (Cell)
  6. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. (Cell)
  7. The microcosmos of cancer (Nature)
  8. 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks (Cell)
  9. The DNA damage response and cancer therapy (Nature)
  10. The diverse biological roles of mammalian PARPS, a small but powerful family of poly-ADP-ribose polymerases. (Frontiers in Bioscience)

Their papers